Monopar Therapeutics Inc (MNPR)
0.669
+0.01
(+1.36%)
USD |
NASDAQ |
May 03, 10:05
Monopar Therapeutics Cash from Investing (Quarterly): 2.970M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.970M |
| September 30, 2023 | -0.0131M |
| June 30, 2023 | 2.954M |
| March 31, 2023 | -0.9834M |
| Date | Value |
|---|---|
| December 31, 2022 | -4.918M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.918M
Minimum
Dec 2022
2.970M
Maximum
Dec 2023
0.0012M
Average
--
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Motus GI Holdings Inc | 0.00 |
| SeaStar Medical Holding Corp | -- |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.546M |
| Cash from Financing (Quarterly) | 0.3345M |
| Free Cash Flow | -7.858M |
| Free Cash Flow Per Share (Quarterly) | -0.1056 |
| Free Cash Flow Yield | -84.99% |